BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

NCT05370430 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: BAFFR-CAR T cells

Sponsor

PeproMene Bio, Inc.

Collaborators

[object Object]